Petra Hoffknecht

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer

Michael Thomas, Christian Rübe, Petra Hoffknecht et al. · The Lancet Oncology · 2008 · 346 citations

Medicine, Oncology, Surgery +16

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

Petra Hoffknecht, Amanda Tufman, Thomas Wehler et al. · Journal of Thoracic Oncology · 2014 · 252 citations · Full text

Medicine, Oncology, Pharmacology +16

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Martin Sebastian, Wilfried Eberhardt, Petra Hoffknecht et al. · Lung Cancer · 2021 · 79 citations · Full text

Medicine, Genetics, Oncology +16

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)

Martin Faehling, Christian Schumann, Petros Christopoulos et al. · Lung Cancer · 2020 · 75 citations

Medicine, Oncology, Radiation Oncology +15

Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany

Jan Stratmann, Friederike C. Althoff, Paula Doebel et al. · European Journal of Cancer · 2024 · 43 citations · Full text

Medicine, Oncology, Pharmacology +13